Reply to Francesco Montorsi, Eugenio Ventimiglia, and Andrea Salonia's Letter to the Editor re: Panagiotis Kallidonis, Constantinos Adamou, Dimitrios Kotsiris, et al. Combination Therapy with Alpha-blocker and Phosphodiesterase-5 Inhibitor for Improving Lower Urinary Tract Symptoms and Erectile Dysfunction in Comparison with Monotherapy: A Systematic Review and Meta-analysis. Eur Urol Focus 2020;6:537-58

Eur Urol Focus. 2021 Sep;7(5):1209. doi: 10.1016/j.euf.2020.09.006. Epub 2020 Sep 22.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adrenergic alpha-Antagonists
  • Cyclic Nucleotide Phosphodiesterases, Type 5
  • Erectile Dysfunction*
  • Humans
  • Lower Urinary Tract Symptoms*
  • Male
  • Phosphodiesterase 5 Inhibitors

Substances

  • Adrenergic alpha-Antagonists
  • Phosphodiesterase 5 Inhibitors
  • Cyclic Nucleotide Phosphodiesterases, Type 5